Lorcaserin HCl phase 3 trials in obese and overweight patients: week 52 outcomes for those achieving at least 5% weight loss at week 12: a per prescribing information analysis Meeting Abstract

International Collaboration

cited authors

  • Finer, N., Smith, S., Sanchez, M., Fraher, K., Stubbe, S., Turner, C., Raether, B., Halliday, D., Krolikowski, J., Fain, R., Shanahan, W. R.

authors

Publication Date

  • September 1, 2013

webpage

published in

category

start page

  • S259

end page

  • S260

volume

  • 56

WoS Citations

  • 0

WoS References

  • 0